Dimitri recently joined Catapult Capital Management, and New York-based investment manager, investing primarily in the North American capital markets. Before this role, he was a Senior Analyst with Iguana Healthcare Partners, which invests long/short globally in public companies in the healthcare industry. Before Iguana, Dimitri held roles focusing on the biotechnology industry at Guggenheim Partners and Oppenheimer & Co.
Dimitri was an Associate and Kauffman Fellow at ProQuest Investments for nearly 6 years, where he provided technical consultation to ProQuest while pursuing academic research in molecular biology at Princeton University. While at Princeton, he led numerous research projects in the area of human virology, immunology and genomics. In addition, Dimitri has co-authored several clinical papers in dermatology.
Dimiri spent almost five years on the VC side, another two years on the sell-side, and is currently focusing on investments in public healthcare companies.
Education, Personal, and Fellowship
Dimitri received his PhD in molecular biology from Princeton University. He earned a BS degree in biochemistry, genetics, zoology and German literature from the University of Wisconsin at Madison, where he graduated with Honors and Departmental Citations. While at Wisconsin, Dimitri received the United Nations Merit Scholarship from the International Institute of Education. Dimitri has extensive international experience and speaks five foreign languages.
Dimitri is a member of Kauffman Fellows Class 12 and served his fellowship under mentor Jay Moorin at ProQuest Investments.